Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RH Genotype Matched Red Cells for Patients With Sickle Cell Disease and Anti-D
NCT04156906Phase 1Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jul 2020
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in sickle cell disease (SCD), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Anti-D Recurrence at 10 months. Started Jul 2020; status: completed.
02
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04156906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156906.